Xencor

Endeavor Biomedicines Inc. is a clinical-stage biotechnology company based in San Diego, California, focused on developing innovative medicines aimed at delivering transformational clinical benefits to patients with life-threatening diseases. Their leading investigational candidates include ENV101, an inhibitor of the Hedgehog signaling pathway for treating fibrotic lung diseases, and ENV501, a targeted antibody-drug conjugate for HER3-positive solid tumors. The company's mission is to disrupt disease progression and restore hope by precisely targeting the root causes of illnesses, with a vibrant culture that reflects their commitment to improving patient outcomes. Endeavor Biomedicines is dedicated to developing groundbreaking therapies that not only slow disease progression but also aim to reverse the trajectory of relentless conditions. Generated from the website

Afraxis, Inc is a research and development company based in San Diego, CA. Specializing in innovative solutions, Afraxis, Inc focuses on advancing scientific discoveries in various fields. Generated from their business information

Cullgen Inc, based in San Diego, CA, is at the forefront of innovating protein degradation technology aimed at developing effective treatments for debilitating diseases. The company's vision centers on transforming the drug design paradigm by creating targeted protein degraders that can address previously untreatable conditions. Utilizing their cutting-edge uSMITE technology and novel E3 ligands, Cullgen builds robust protein degraders for cancer and other serious ailments. Committed to expanding the limits of what's possible in medicine, the company aims to provide remedies that significantly improve patient outcomes. Generated from the website